Brent Sabatini serves as SVP, Chief Accounting Officer at Vir Biotechnology, Inc., where they oversee executive responsibilities. Since joining the company, Brent Sabatini has executed 1 insider transactions totaling $13.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 24, 2026 involved selling 1,430 shares valued at $13.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | VIR | $13.6K | Sale | 1,430 | $9.53 | Discretionary |
Brent Sabatini currently holds 69,613 shares of Vir Biotechnology, Inc. (VIR), valued at approximately $0. This represents their equity stake as SVP, Chief Accounting Officer.
Based on SEC Form 4 filings, Brent Sabatini has been a net seller of VIR stock. They have purchased $0 and sold $13.6K worth of shares.
Brent Sabatini's most recent insider trade was on Feb 24, 2026, when they sold 1,430 shares at $9.53 per share.
Get notified when new Form 4 filings are submitted